Abstract
The UK pharmaceutical services firm Sygnature Discovery is loaning its Tecan multisample automated pipetting machine to a network of government labs for testing COVID-19. The machine will enable rapid multiple sample analysis. Sygnature had been using the machine for chemical library development but will scale back that work while it is on loan. The company has also created an antiviral drug discovery team to support firms seeking compounds to combat COVID-19.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
